Pacira BioSciences, Inc. (PCRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 5401 WEST KENNEDY BOULEVARD
TAMPA, FL 33609
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments220,766173,999288,651328,725316,393452,194
Cash and cash equivalents86,81035,545104,139109,424122,061226,751
Short-term investments133,956138,454184,512219,301194,332225,443
Receivables99,07993,20598,39793,47191,10592,103
Inventory, net of allowances, customer advances and progress billings92,13092,97796,06396,799100,588103,662
Inventory92,13092,97796,06396,799100,588103,662
Other undisclosed current assets17,34915,93315,22314,41618,12419,059
Total current assets:429,324376,114498,334533,411526,210667,018
Noncurrent Assets
Operating lease, right-of-use asset65,83768,08470,87769,66272,08274,271
Property, plant and equipment180,310181,617183,512193,646191,279189,767
Long-term investments and receivables  8,28137,20917,394  
Long-term investments  8,28137,20917,394  
Intangible assets, net (including goodwill)675,145689,467703,789738,363741,456755,368
Goodwill163,243163,243163,243157,361146,132145,722
Intangible assets, net (excluding goodwill)511,902526,224540,546581,002595,324609,646
Deferred income tax assets156,140167,570160,309155,531167,149169,282
Other undisclosed noncurrent assets35,62532,28527,17026,35835,81235,770
Total noncurrent assets:1,113,0571,147,3041,182,8661,200,9541,207,7781,224,458
TOTAL ASSETS:1,542,3811,523,4181,681,2001,734,3651,733,9881,891,476
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities80,42778,894105,00589,29091,269103,375
Taxes payable11863
Accounts payable24,20617,26115,22012,93313,98314,843
Accrued liabilities56,22161,63389,78576,35777,27587,669
Debt19,50410,85333,64833,87233,776193,680
Other undisclosed current liabilities8,9818,9519,1218,3648,1348,018
Total current liabilities:108,91298,698147,774131,526133,179305,073
Noncurrent Liabilities
Long-term debt and lease obligation532,183542,918655,823779,400789,453799,453
Long-term debt, excluding current maturities532,183542,918655,823713,999721,878729,743
Liabilities, other than long-term debt71,82974,02177,67119,11219,47320,847
Deferred revenue      10,125
Deferred compensation liability, classified   3,200   
Other liabilities11,78311,5799,66919,11219,47310,722
Operating lease, liability60,04662,44264,80265,40167,57569,710
Other undisclosed noncurrent liabilities21,48239,74024,92234,20435,24756,527
Total noncurrent liabilities:625,494656,679758,416832,716844,173876,827
Total liabilities:734,406755,377906,190964,242977,3521,181,900
Equity
Equity, attributable to parent807,975768,041775,010770,123756,636709,576
Common stock464646464645
Additional paid in capital950,626936,419924,095909,396895,151867,890
Accumulated other comprehensive loss(173)(137)(380)(670)(605)(527)
Accumulated deficit(142,524)(168,287)(148,751)(138,649)(137,956)(157,832)
Total equity:807,975768,041775,010770,123756,636709,576
TOTAL LIABILITIES AND EQUITY:1,542,3811,523,4181,681,2001,734,3651,733,9881,891,476

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues169,467160,341171,955167,466169,411157,991
Cost of revenue(48,207)(49,020)(61,916)(50,678)(50,627)(36,074)
Gross profit:121,260111,321110,039116,788118,784121,917
Operating expenses(98,932)(102,305)(95,797)(95,010)(105,607)(100,187)
Other undisclosed operating income (loss)17,549(12,107)(24,135)(489)18,058(4,337)
Operating income (loss):39,877(3,091)(9,893)21,28931,23517,393
Nonoperating expense(2,023)(23,383)(8,175)(19,220)(9,228)(10,099)
Investment income, nonoperating2,1113,1422,7851,234252271
Other nonoperating income (expense)(269)(10)81(10,598)(647)(124)
Interest and debt expense(3,865)(16,926)(11,041)(9,856)(8,833)(10,246)
Income (loss) from continuing operations before equity method investments, income taxes:33,989(43,400)(29,109)(7,787)13,174(2,952)
Other undisclosed income from continuing operations before income taxes3,86516,92611,0419,8568,83310,246
Income (loss) from continuing operations before income taxes:37,854(26,474)(18,068)2,06922,0077,294
Income tax expense (benefit)(12,091)6,9387,966(2,762)(2,131)(466)
Income (loss) from continuing operations:25,763(19,536)(10,102)(693)19,8766,828
Income (loss) before gain (loss) on sale of properties:(693)19,8766,828
Net income (loss) available to common stockholders, basic:25,763(19,536)(10,102)(693)19,8766,828
Dilutive securities, effect on basic earnings per share     1,039 
Other undisclosed net loss available to common stockholders, diluted   (3,112)   
Net income (loss) available to common stockholders, diluted:25,763(19,536)(13,214)(693)20,9156,828

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):25,763(19,536)(10,102)(693)19,8766,828
Comprehensive income (loss):25,763(19,536)(10,102)(693)19,8766,828
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(36)243290(65)(78)(694)
Comprehensive income (loss), net of tax, attributable to parent:25,727(19,293)(9,812)(758)19,7986,134

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: